International Consensus Defines the Role of Intestinal Ultrasound in Postoperative Crohn’s Disease Surveillance : Lancet Gastroenterol Hepatol | May 2026

Introduction

Crohn's Disease recurrence after ileocolic resection remains common, with postoperative endoscopic recurrence often preceding clinical symptoms. Early identification of recurrence is critical because timely therapeutic escalation may prevent progression to stricturing disease, repeat surgery and irreversible bowel damage. Although ileocolonoscopy remains the reference standard, increasing interest has emerged around Intestinal Ultrasound as a non-invasive, repeatable and patient-friendly monitoring tool.

Problem Statement

Despite growing clinical adoption of intestinal ultrasound in inflammatory bowel disease, there has been no international consensus regarding standardized implementation, interpretation and timing of ultrasound assessment for postoperative Crohn’s disease recurrence.

Summary

This international multidisciplinary RAND/UCLA appropriateness study established expert consensus recommendations for the use of intestinal ultrasound in detecting and evaluating postoperative recurrence after ileocolic resection in Crohn’s disease.

The recommendations were developed through a rigorous consensus methodology incorporating systematic literature review, iterative expert voting and multidisciplinary ratification involving gastroenterologists, colorectal surgeons and radiologists from multiple countries. The resulting framework represents one of the most comprehensive attempts to standardize postoperative intestinal ultrasound assessment in Crohn’s disease.

The panel identified several key anatomic regions that should routinely be evaluated during postoperative sonographic assessment. Particular emphasis was placed on detailed examination of the neoterminal ileum and the inlet of the neoterminal ileum, which were considered the sites most likely to reflect clinically meaningful postoperative recurrence. Additional evaluation of the blind limbs of the anastomosis, distal colonic segments and surrounding mesentery was also recommended.

Importantly, the consensus expanded assessment beyond bowel wall thickness alone. Recommended sonographic parameters included bowel wall stratification, vascularity, mesenteric inflammatory fat, lymphadenopathy, luminal narrowing and detection of penetrating or stricturing complications such as abscesses, fistulas and prestenotic dilation. This reflects the increasingly sophisticated role of intestinal ultrasound as a comprehensive transmural disease assessment tool rather than merely a surrogate for mucosal inflammation.

The panel also addressed timing of surveillance. Intestinal ultrasound was not recommended within the first four postoperative weeks because early inflammatory and healing-related changes may confound interpretation. Instead, the first formal postoperative assessment was recommended between 3 and 12 months after surgery, aligning with the biologic window during which early recurrence commonly develops.

A particularly important aspect of the recommendations is the recognition of mesenteric assessment as a core component of postoperative surveillance. Increasing evidence suggests that mesenteric inflammation and creeping fat are integral drivers of Crohn’s disease progression, and intestinal ultrasound uniquely allows simultaneous bowel and mesenteric evaluation in real time.

Clinically, these recommendations may substantially expand adoption of ultrasound-driven postoperative monitoring pathways. Compared with ileocolonoscopy, intestinal ultrasound offers several practical advantages including absence of sedation, lack of bowel preparation, repeatability, lower procedural burden and potential for point-of-care assessment during routine clinic visits.

The study also reflects the broader paradigm shift within inflammatory bowel disease toward transmural monitoring. While endoscopy remains essential, cross-sectional modalities increasingly provide complementary information regarding deep tissue inflammation, fibrosis and penetrating complications that are not fully captured by mucosal visualization alone.

Importantly, the panel emphasized that development of validated postoperative ultrasound indices remains a major unmet need. Standardized scoring systems integrating bowel wall thickness, vascularity and mesenteric findings will likely be essential for future clinical trial integration and treat-to-target strategies.

Overall, this multidisciplinary international consensus establishes a standardized framework for intestinal ultrasound assessment of postoperative Crohn’s disease recurrence. The recommendations support intestinal ultrasound as an increasingly important non-invasive monitoring modality and provide critical groundwork for future validation studies and precision postoperative surveillance strategies in Crohn’s disease.